Bastide le Confort Medical SA
PAR:BLC

Watchlist Manager
Bastide le Confort Medical SA Logo
Bastide le Confort Medical SA
PAR:BLC
Watchlist
Price: 27.8 EUR -3.3%
Market Cap: 204.9m EUR

Intrinsic Value

The intrinsic value of one BLC stock under the Base Case scenario is 88.52 EUR. Compared to the current market price of 27.8 EUR, Bastide le Confort Medical SA is Undervalued by 69%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

BLC Intrinsic Value
88.52 EUR
Undervaluation 69%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Bastide le Confort Medical SA

What is Valuation History?
Compare BLC to

Fundamental Analysis

Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about BLC?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Bastide le Confort Medical SA
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Bastide le Confort Medical SA

Current Assets 231.8m
Cash & Short-Term Investments 150k
Receivables 137.2m
Other Current Assets 94.5m
Non-Current Assets 444.2m
Long-Term Investments 919k
PP&E 217.9m
Intangibles 217.2m
Other Non-Current Assets 8.2m
Efficiency

Free Cash Flow Analysis
Bastide le Confort Medical SA

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Bastide le Confort Medical SA

Revenue
540.3m EUR
Cost of Revenue
-175.4m EUR
Gross Profit
364.9m EUR
Operating Expenses
-323.4m EUR
Operating Income
41.5m EUR
Other Expenses
-39.8m EUR
Net Income
1.7m EUR
Fundamental Scores

BLC Profitability Score
Profitability Due Diligence

Bastide le Confort Medical SA's profitability score is 47/100. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Gross Margin is Increasing
Operating Margin is Increasing
47/100
Profitability
Score

Bastide le Confort Medical SA's profitability score is 47/100. The higher the profitability score, the more profitable the company is.

BLC Solvency Score
Solvency Due Diligence

Bastide le Confort Medical SA's solvency score is 33/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low Altman Z-Score
Positive Net Debt
33/100
Solvency
Score

Bastide le Confort Medical SA's solvency score is 33/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BLC Price Targets Summary
Bastide le Confort Medical SA

Wall Street analysts forecast BLC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BLC is 33.66 EUR with a low forecast of 31.31 EUR and a high forecast of 36.75 EUR.

Lowest
Price Target
31.31 EUR
13% Upside
Average
Price Target
33.66 EUR
21% Upside
Highest
Price Target
36.75 EUR
32% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for BLC is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one BLC stock?

The intrinsic value of one BLC stock under the Base Case scenario is 88.52 EUR.

Is BLC stock undervalued or overvalued?

Compared to the current market price of 27.8 EUR, Bastide le Confort Medical SA is Undervalued by 69%.

Back to Top